References
1. Wu J T, Leung K, and Leung G M, Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. The Lancet, 2020.395 (10225): p. 689-697.
2. Liu Y, Gayle A A, Wildersmith A, and Rocklov J, The reproductive number of COVID-19 is higher compared to SARS coronavirus.Journal of Travel Medicine, 2020. 27 (2).
3. Al-Tawfiq J A, Asymptomatic coronavirus infection: MERS-CoV and SARS-CoV-2 (COVID-19). Travel Med Infect Dis, 2020.27 (101608): p. 1-2.
4. Novel C P E R E, The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China.Zhonghua liu xing bing xue za zhi= Zhonghua liuxingbingxue zazhi, 2020.41 (2): p. 145.
5. Protocol for the Management of Asymptomatic Persons Infected with COVID-19 Virus.Joint Taskforce on COVID-19 Prevention and Control,  China State Council
6. Junfen L, Mengna W, Haocheng W, Tao Z, Chen W, and Fudong L,Epidemiological characteristics of coronavirus disease 2019 in Zhejiang Province. Prev Med, 2020. 32 (03): p. 217-221+225.
7. Biyao L, Xiaohua Q, Min J, and Zhen W, Epidemiological characteristics of imported COVID-19 cases from aboard to Zhejiang Province Preventive Medicine, 2020: p. 1-9.
8. Hu S, Xu Q, Luo K, Yang H, Sun Q, Liu Z, et al.,Epidemiological characteristics of patients with coronavirus disease 2019 in Hunan province. Pract Prev Med, 2020. 27 (04): p. 385-388.
9. Jincheng L, Qin X, Yan W, Jie X, Yao H, Wenjun L, et al.,Analysis in characteristics of asymptomatic infection patients with coronavirus disease 2019 in Yangzhou City of Jiangsu Province.Journal of Clinical Medicine in Practice, 2020. 24 (05): p. 10-13.
10. Pan X, Chen D, Xia Y, Wu X, Li T, Ou X, et al., Asymptomatic cases in a family cluster with SARS-CoV-2 infection. The Lancet Infectious Diseases, 2020. 20 (4): p. 410-411.
11. Bai Y, Yao L, Wei T, Tian F, Jin D, Chen L, et al., Presumed asymptomatic carrier transmission of COVID-19. Jama, 2020.323 (14): p. 1406-1407.
12. Li P, Fu J, Li K, Chen Y, Wang H, Liu L, et al., Transmission of COVID-19 in the terminal stage of incubation period: a familial cluster. International Journal of Infectious Diseases, 2020.
13. Tong Z, Tang A, Li K, Li P, Wang H, Yi J, et al., Potential presymptomatic transmission of SARS-CoV-2, Zhejiang province, China, 2020. Emerging infectious diseases, 2020. 26 (5): p. 1052.
14. Liu X, Liu F, Fan Q, Zheng W, Zhang D H, Zhang Q L, et al.,Report of COVID-19 family clustering epidemic caused by asymptomatic infection. Chin J Public Health, 2020. 36 (03): p. 282-284.
15. Qian G, Yang N, Ma A H Y, Wang L, Li G, Chen X, et al.,COVID-19 Transmission Within a Family Cluster by Presymptomatic Carriers in China. Clinical Infectious Diseases, 2020.
16. Ma W, Su  B, Wu J, Chen F, Bu T, Cheng X, et al., Report of COVID-19 family clustering epidemic caused by asymptomatic infection.Chin J Public Health, 2020. 36 (03): p. 277-281.
17. Tian Y, Wu Z, Han X, Wang Y, and Liu H, Epidemiological investigation on the first family aggregation epidemic of novel coronavirus pneumonia in Yangzhou Shanghai Journal of Preventive Medicine, 2020: p. 1-7.DOI: https://doi.org/10.19428/j.cnki.sjpm.2019.20117.
18. Liu G and Ma ZL,Family clustering of novel coronavirus disease 2019 in Liaoning province: a brief report. Chin J Public Health,, 2020.36 (03): p. 293-294.
19. Li C, Wu B, Luo F, and Zhang N, Clinical Study and CT Findings of a Familial Cluster of Pneumonia with Coronavirus Disease 2019 (COVID-19) J Sichuan Univ ( Med Sci Edi ), 2020. 51 (02): p. 155-158.
20. Ye F, Xu S, Rong Z, Xu R, Liu X, Deng P, et al., Delivery of infection from asymptomatic carriers of COVID-19 in a familial cluster.International Journal of Infectious Diseases, 2020.
21. Yang YL, Li LH , LI CF, YC X, and J P,A survey on clustering of novel coronavirus disease in families in Fengjie county of Chongqing municipality. Chin J Public Health, 2020.36 (03): p. 285-288.
22. Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al., Clinical characteristics of coronavirus disease 2019 in China. New England journal of medicine, 2020. 382 (18): p. 1708-1720.
23. Xu Y, Li X, Zhu B, Liang H, Fang C, Gong Y, et al.,Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nature medicine, 2020.26 (4): p. 502-505.
24. Dong Y, Fan Q, Wang Y, Li Y, Xia J, Yao J, et al., Analysis in nucleic acid test results of patients with coronavirus disease 2019 in Yangzhou City of Jiangsu Province. Journal of Clinical Medicine in Practice, 2020. 24 (05): p. 6-9.
25. Hu Z, Song C, Xu C, Jin G, Chen Y, Xu X, et al., Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. Science China Life Sciences, 2020: p. 1-6.
26. Tan C, Xiao Y, Meng X, Huang X, Li C, and Wu A, Asymptomatic SARS-CoV-2 infections: what we need to know? Infection Control & Hospital Epidemiology, 2020: p. 1-7.
27. Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, et al.,SARS-CoV-2 viral load in upper respiratory specimens of infected patients. New England Journal of Medicine, 2020. 382 (12): p. 1177-1179.
28. Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al., Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. New England Journal of Medicine, 2020.382 (10): p. 970-971.
29. Lei M Y, Huang Y, Gou Y, Ping K K, Liu S B, Yao G H, et al.,Characteristics of cluster epidemic of 2019 novel coronavirus disease in Guizhou province. Chin J Public Health, 2020: p. 1-5.
30. Liu Y C, Liao C H, Chang C F, Chou C C, and Lin Y R, A locally transmitted case of SARS-CoV-2 infection in Taiwan. New England Journal of Medicine, 2020. 382 (11): p. 1070-1072.
31. Lai C-C, Shih T-P, Ko W-C, Tang H-J, and Hsueh P-R, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges. International journal of antimicrobial agents, 2020: p. 105924.
32. Yu P, Zhu J, Zhang Z, and Han Y, A familial cluster of infection associated with the 2019 novel coronavirus indicating possible person-to-person transmission during the incubation period. The Journal of infectious diseases, 2020. 221 (11): p. 1757-1761.
33. Xuzhou municipal health commission. Notification of the epidemic (no. 38) http://www.xzcdc.com/index.php/news/15484.html.
34. Inui S, Fujikawa A, Jitsu M, Kunishima N, Watanabe S, Suzuki Y, et al., Chest CT findings in cases from the cruise ship “Diamond Princess” with coronavirus disease 2019 (COVID-19). Radiology: Cardiothoracic Imaging, 2020. 2 (2): p. e200110.
35. Wang Y, Chen J, and Wang X, CT image features of asymptomatic patients with novel coronavirus pneumonia. Medical Journal of Wuhan University, 2020. 41 (03): p. 353-356.
36. Asadi S, Bouvier N, Wexler A S, and Ristenpart W D, The coronavirus pandemic and aerosols: Does COVID-19 transmit via expiratory particles? 2020, Taylor & Francis.
37. Booth T F, Kournikakis B, Bastien N, Ho J, Kobasa D, Stadnyk L, et al., Detection of airborne severe acute respiratory syndrome (SARS) coronavirus and environmental contamination in SARS outbreak units. The Journal of infectious diseases, 2005. 191 (9): p. 1472-1477.
38. van Doremalen N, Bushmaker T, Morris D H, Holbrook M G, Gamble A, Williamson B N, et al., Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. New England Journal of Medicine, 2020. 382 (16): p. 1564-1567.
39. JP D, The size and the duration of air-carriage of respiratory droplets and droplet-nuclei. Epidemiology & Infection, 1946.44 (6): p. 471-479.
40. PAPINENI R S and ROSENTHAL F S, The size distribution of droplets in the exhaled breath of healthy human subjects. Journal of Aerosol Medicine, 1997. 10 (2): p. 105-116.
41. Morawska L, Johnson G, Ristovski Z, Hargreaves M, Mengersen K, Corbett S, et al., Size distribution and sites of origin of droplets expelled from the human respiratory tract during expiratory activities. Journal of Aerosol Science, 2009. 40 (3): p. 256-269.
42. Asadi S, Wexler A S, Cappa C D, Barreda S, Bouvier N M, and Ristenpart W D, Aerosol emission and superemission during human speech increase with voice loudness. Scientific reports, 2019.9 (1): p. 1-10.
43. Lu X, Zhang L, Du H, Zhang J, Li Y Y, Qu J, et al., SARS-CoV-2 infection in children. New England Journal of Medicine, 2020.382 (17): p. 1663-1665.
44. Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, et al.,Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics, 2020.
45. Wei M, Yuan J, Liu Y, Fu T, Yu X, and Zhang Z-J, Novel coronavirus infection in hospitalized infants under 1 year of age in China. Jama, 2020. 323 (13): p. 1313-1314.
46. Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al., Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. The Lancet, 2020. 395 (10226): p. 809-815.
47. Zeng L, Tao X, Yuan W, Wang J, Liu X, and Liu Z, First case of neonate infected with novel coronavirus pneumonia in China. Zhonghua er ke za zhi= Chinese journal of pediatrics, 2020. 58 : p. E009.
48. Cao Q, Chen Y, Chen C, and Chiu C, SARS-CoV-2 infection in children: Transmission dynamics and clinical characteristics. Journal of the Formosan Medical Association, 2020. 119 (3): p. 670.
49. JW V t W, R P, and R V F, The role of BCG/PPD‐activated macrophages in resistance against systemic candidiasis in mice.Scandinavian journal of immunology, 1992. 36 (5): p. 713-720.
50. Netea M G, Schlitzer A, Placek K, Joosten L A, and Schultze J L,Innate and adaptive immune memory: an evolutionary continuum in the host’s response to pathogens. Cell host & microbe, 2019.25 (1): p. 13-26.
51. Nishiura H, Kobayashi T, Miyama T, Suzuki A, Jung S, Hayashi K, et al., Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19). medRxiv, 2020.
52. Battegay M, Kuehl R, Tschudin-Sutter S, Hirsch H H, Widmer A F, and Neher R A, 2019-novel Coronavirus (2019-nCoV): estimating the case fatality rate–a word of caution. Swiss medical weekly, 2020.150 (0506).
53. Information from the official website of the National Health Commissionhttp://www.nhc.gov.cn/xcs/xxgzbd/gzbd_index.shtml
54. Mizumoto K, Kagaya K, Zarebski A, and Chowell G, Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020.Eurosurveillance, 2020. 25 (10): p. 2000180.
55. Qiu J, Covert coronavirus infections could be seeding new outbreaks. Nature, 2020.